Certara, Inc. CERT 深 沪
已收盘 02-06 16:00:00 美东时间
7.23
-0.150
-2.03%
华盛通- 最 高7.50
- 今 开7.39
- 成交量 511.26万股
- 最 低 7.16
- 昨 收 7.38
- 总市值 11.52亿
- 52周最高 15.38
- 市盈率 静 --
- 换手率 3.21%
- 52周最低 7.16
- 委 比 42.05%
- 总股本 1.59亿
- 历史最高 45.48
- 量 比 1.54
- 振 幅 4.61%
- 历史最低 7.16
- 每 手 1
- 风险率 1.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
Certara Inc. (Nasdaq: CERT), a global leader in model-informed drug development, will release its 2025 fourth-quarter and full-year financial results on February 26, 2026. Management will host a conference call at 8:30 AM ET, requiring investors to register online in advance. A live and archived webcast will be available on Certara's investor website.
01-29 13:30
Analysts Offer Insights on Healthcare Companies: Humana (HUM), Certara (CERT) and Edgewise Therapeutics (EWTX)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
01-27 20:40
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
Deep Dive Into Certara Stock: Analyst Perspectives (6 Ratings)
Throughout the last three months, 6 analysts have evaluated Certara (NASDAQ:CER...
01-07 04:01
Leerink Partners Upgrades Certara to Outperform, Announces $13 Price Target
Leerink Partners analyst Michael Cherny upgrades Certara (NASDAQ:CERT) from Market Perform to Outperform and announces $13 price target.
01-07 03:46
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $12
Morgan Stanley analyst Sean Laaman maintains Certara (NASDAQ:CERT) with a Equal-Weight and lowers the price target from $16 to $12.
2025-12-19 01:42
美股大行评级 | 潜在涨幅113%！麦格理首予小马智行“跑赢大市"评级目标价29美元；Roth Capital下调好市多至"卖出"，目标价从906美元降至769美元
今日重点评级关注：HC Wainwright & Co.：维持BioCryst Pharma"买入"评级，目标价从30美元升至32美元；TD Cowen：上调Milestone Pharmaceuticals评级至"买入"，目标价8美元
2025-12-16 09:36
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
2025-12-15 15:30
